Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs JD.Com Inc (JD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs JD.Com Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.38 (market cap $4.03B), while JD.Com Inc trades at $27.3 (market cap $36.93B). The key difference: JD.Com Inc is far larger — about 9.2× Indivior Pharmaceuticals Inc. Common Stock's market cap, and JD.Com Inc pays a 3.75% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and JD.Com Inc for 86 Days on average.
| INDV | JD | |
|---|---|---|
Market Cap | $4.03B | $36.93B |
Volume | 2,781,171 | 6,680,917 |
Sector | Health | Consumer Cyclical |
52-Week High | $41.83 | $34.53 |
52-Week Low | $24.09 | $25.19 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $4.32B | $19.54B |
Dividend Yield | — | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JD.com trades at $26.78, up 0.22% with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth to $1.31 trillion in 2025 but faces margin compression with net income declining to $19.63 billion. Valuation metrics appear attractive with P/E of 17.71 and P/S of 0.2, while analyst consensus remains bullish with a $35.38 price target. Recent news highlights JD's potential EU approval for its $2.5 billion Ceconomy acquisition and Michael Burry's increased position.
JD presents a compelling value opportunity with deep discount to intrinsic value estimates of $50-60, though near-term headwinds include Chinese regulatory scrutiny and competitive pressures. The stock's risk-reward appears favorable given strong cash flow generation and robust balance sheet with $234 billion cash position, but investors should monitor execution on international expansion and margin recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →
